Abstract
After completing this article, readers should be able to: 1. Explain when fetal cells pass into a pregnant woman and maternal cells pass into the fetus. 2. Explain findings of fetal cells in women who have systemic sclerosis. 3. List autoimmune diseases in which fetal cells have been found in target tissues. 4. Describe the prevalence of maternal cells in blood and muscle of patients who have juvenile idiopathic inflammatory myositis. 5. Characterize the influence of human leukocyte antigen compatibility with her children on a woman’s risk for developing systemic sclerosis. It is now recognized that cells traffic between fetus and mother during pregnancy. Fetal cells have been found to persist for years, probably for a lifetime, in the circulation of normal women. The term chimerism is used when one individual harbors cells from another individual, and the term microchimerism refers to low levels of chimerism. Chronic graft-versus-host disease (GVHD) is a condition of human chimerism that has similarities to some autoimmune diseases. Women have a predilection to autoimmune disease, and human leukocyte antigen (HLA) class II genes are known to be important both in autoimmune disease and in GVHD. Considered together, these observations led to the hypothesis that microchimerism and HLA genes of host and nonhost cells are involved in autoimmune disease. Alternative sources of microchimerism could affect men and women who have never been pregnant, including from a twin, from a blood transfusion, or long-term persistence of maternal cells that have trafficked to the fetal circulation during pregnancy. Studies of systemic sclerosis (SSc), primary biliary cirrhosis (PBC), Sjogren syndrome, pruritic eruption of pregnancy, myositis, and thyroid disease have both lent support and raised doubts about the role of microchimerism in autoimmune disease. Fetal cells pass into the maternal circulation during normal human pregnancy. Fetal microchimerism during pregnancy is detected most readily in plasma …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.